Skip to main content
Clinical Trials/EUCTR2010-020185-19-CZ
EUCTR2010-020185-19-CZ
Active, not recruiting
Not Applicable

Optimization of Treatment and Management of Schizophrenia in Europe - OPTiMiSE

niversity Medical Center Utrecht0 sites350 target enrollmentFebruary 23, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia ICD-10 code F20 or schizophreniform disorder ICD-10 code F23.1
Sponsor
niversity Medical Center Utrecht
Enrollment
350
Status
Active, not recruiting
Last Updated
10 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 23, 2011
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \-Diagnosis of schozophrenia, schizophreniform or schizoaffective disorder as defined by DSM\-IV on the basis of the Mini International Neuropsychiatric Interview Plus (M.I.N.I. Plus;Sheehan et al. 1998\).
  • \-Age 18\-40 years
  • \-Written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • \-A time interval between the onset of positive symptoms (hallucinations and/or delusions) and study entry exceeding two years.
  • \-Prior use of antipsychotic medication longer than an episode of two weeks in the previous year and/or 6 weeks lifetime.
  • \-Intolerance to one of the drugs in this study.
  • \-Patients who are coercively treated at a psychiatric ward (based on a judicial ruling)
  • \-Patients who are represented by a legal ward or under legal custody
  • \-The presence of one or more of the contraindications against any of the study drugs as mentioned in the IB texts
  • \-Pregnancy or lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Optimization of Treatment and Management of Schizophrenia in Europe - OPTiMiSESchizophrenia ICD-10 code F20 or schizophreniform disorder ICD-10 code F23.1MedDRA version: 12.1Level: LLTClassification code 10039626Term: SchizophreniaMedDRA version: 12.1Level: LLTClassification code 10039647Term: Schizophreniform disorder
EUCTR2010-020185-19-GBniversity Medical Centre Utrecht446
Active, not recruiting
Phase 1
Optimising treatment of patient suffering from schizophrenia in Europe
EUCTR2010-020185-19-BEniversity Medical Center Utrecht446
Active, not recruiting
Phase 1
Optimising treatment of patient suffering from schizophrenia in EuropeSchizophrenia ICD-10 code F20 or schizophreniform disorder ICD-10 code F23.1MedDRA version: 16.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 16.1Level: PTClassification code 10039647Term: Schizophreniform disorderSystem Organ Class: 10037175 - Psychiatric disorders
EUCTR2010-020185-19-DEniversity Medical Center Utrecht500
Completed
Phase 3
Optimization of Treatment and Management of Schizophrenia in Europepsychotic disorder10039628
NL-OMON41244niversitair Medisch Centrum Utrecht50
Active, not recruiting
Phase 1
Optimising treatment of patient suffering from schizophrenia in EuropeSchizophrenia ICD-10 code F20 or schizophreniform disorder ICD-10 code F23.1MedDRA version: 19.0Level: HLTClassification code 10039620Term: Schizoaffective and schizophreniform disordersSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 19.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
EUCTR2010-020185-19-ROniversity Medical Center Utrecht500